MJFF will use H1’s AI-enabled platform to evaluate treatment approaches and improve clinical trial access for patients with Parkinson’s from marginalized communities.
MJFF will use H1’s AI-enabled platform to evaluate treatment approaches and improve clinical trial access for patients with Parkinson’s from marginalized communities.